Dr. Ong Wee Kiat

.

Lecturer
School of Pharmacy

ong.weekiat@monash.edu
+603 5514 4973
Room  2-5-05

Dr Wee Kiat ONG completed his PhD at the University of Strathclyde and was a senior research fellow at the Singapore Bioimaging Consortium of Agency of Science, Technology and Research (A*STAR) in Singapore. He is a registered pharmacist in Malaysia and has experience working in hospital, community and compounding pharmacies.  He was the vice chairman of the Malaysian Pharmaceutical Society (MPS) Johor area committee from 2016-2020. Dr Ong is an Associate Fellow of the UK Higher Education Academy and has taught pharmacy programmes at British university branch campuses in Malaysia. He is passionate about integrating research, science and practice in pharmacy education. His current research interests include translational, ethical and regulatory challenges pertaining to emerging novel therapies and clinical innovation, customised medication, pharmaceutical compounding, veterinary medicine and dosage forms.

Qualifications

- Doctor of Philosophy in Physiology and Pharmacology, University of Strathclyde, 2008

- Master of Science in Marketing (Hons), University of College Dublin, 2014

- Master in Pharmacy (Hons), University of Strathclyde, 2002

- Bachelor of Science in Genetics (Hons), University of Malaya, 1999

Employment History

Dec 2019 - Current: Lecturer, School of Pharmacy, Monash University Malaysia

Jan 2019 - Dec 2019: Compounding Pharmacist, Amber Pharmacy

Mar 2016 - Oct 2018: Locum Pharmacist, AEON Wellness Pharmacy

Aug 2015 - Jun 2019: Lecturer, School of Pharmacy, University of Reading Malaysia

Jul 2010 - Mar 2019: Research Fellow/ Senior Research Fellow/ Adjunct Senior Research Fellow, Singapore Bioimaging Consortium, A*STAR

Aug 2008 - Jun 2010: Assistant Professor, School of Pharmacy, University of Nottingham Malaysia Campus

2004- 2007: Graduate Teaching Assistant, University of Strathclyde

2003-2004: House Pharmacist, Slim River Hospital

Professional Affiliations

Registered Pharmacist, since 2004
Pharmacy Board of Malaysia

Member, Vice Chairman of the Johor Area Committee (2016-2020)
Malaysia Pharmaceutical Society

Member
Stem Cell Society Singapore

Awards and Honours

2019

  • First prize poster presentation at the Malaysian Society of Pharmacology and Physiology Scientific Meeting

2018

  • Singapore Bioimaging Consortium Executive Director's Prize in recognition of service excellence

2017

  • Eli Lilly basic science poster award by Diabetes UK and Eli Lilly at the Diabetes UK annual conference
  • Translational, ethical and regulatory challenges pertaining to emerging novel therapies and clinical innovation
  • Customised medication and pharmaceutical compounding
  • Veterinary medicine and dosage forms

Scholarly Journals (Refereed Only)

2018

Srijaya, T. C., Sriram, S., Cheng, S., Ong, W. K., Rozen, S. G., Abu Kassim, N. H. and Sugii, S. (2018) Xeno-free reprogramming of dental pulp stem cells is associated with amenable epigenetic traits. Stem Cell Res. Ther. 9: 68 (impact factor 4.627, Scopus-indexed)

2017

Dinish, U.S., Wong, C.L., Sriram, S., Ong, W. K., Balasundaram, G., Sugii, S. and Olivio, M. (2017) Diffuse optical spectroscopy and imaging to detect and quantify adipose tissue browning. Sci Rep DOI: 10.1038/srep41357 (impact factor 4.360, Scopus-indexed)

2016

Takeda, K., Sriram, S., Derryn Chan, X. H., Ong, W. K., Yeo, C. R., Tan, B., Lee, S.-A., Kong, K. V., Hoon, S., Jiang, H., Yuen, J. J., Perumal, J., Agrawal, M., Vaz, C., So, J., Shabbir, A., Blaner, W. S., Olivo, M., Han, W., Tanavde, V., Toh, S.-A. and Sugii, S. (2016) Retinoic acid mediates visceral-specific adipogenic defects of human adipose-derived stem cells. Diabetes 65: 1164-1178. (impact factor 8.095, Scopus-indexed)

2014

Ong, W. K., Tan, C. S., Chan, K. L., Goesantoso, G. G., Chan, X. H. D., Chan, E., Yin, J., Chia, R. Y., Khoo, C. M., So, J. B. K., Shabbir, A., Toh, S., Han, W. and Sugii, S. (2014) Identification of specific cell surface markers of adipose-derived stem cells from subcutaneous and visceral fat depots. Stem Cell Reports 2: 171-179. (impact factor 5.365, Scopus-indexed)

Lim, M. H., Ong, W. K. and Sugii, S. (2014) The current landscape of adipose-derived stem cells in clinical applications. Expert Review in Molecular Medicine 16: e8. (impact factor 5.152, Scopus-indexed)

Yaligar, J., Gopalan, V., Ong, W. K., Sugii, S., Shui, G., Lam, B. D., Henry, C. J., Wenk, M. R., Tai, E. S. and Velan, S. S. (2014) Evaluation of dietary effects on hepatic lipids in high fat and placebo diet fed rats by in vivo MRS and LC-MS techniques. PLOS ONE 9: e91436. (impact factor 3.234, Scopus-indexed)

2013

Smith, G. C., Ong, W. K., Costa, J. L., Watson, M., Cornish, J., Grey, A., Gamble, G. D., Dickinson, M., Leung, S., Rewcastle, G. W., Han, W. and Shepherd, P. R. (2013) Extended treatment with selective PI3-kinase and mTOR inhibitors has effects on metabolism, growth, behaviour and bone strength. FEBS J 280: 5337-5349. (impact factor 3.986, Scopus-indexed)

Ong, W. K. and Sugii, S. (2013) Adipose-derived stem cells: fatty potentials for therapy. Int J Biochem & Cell Biol 45: 1083-1086. (impact factor 4.24, Scopus-indexed)

2012

Smith, G. C., Ong, W. K., Rewcastle, G. W., Kendall, J. D., Han, W. and Shepherd, P. R. (2012) Effects of acutely inhibiting PI3K isoforms and mTOR on regulation of glucose metabolism in vivo. Biochem J 442: 161-169. (impact factor 4.654, Scopus-indexed)

2009

Ong, W. K., Gribble, F. M., Reimann, F., Lynch, M. J., Baillie, G. S., Houslay, M. D., Furman, B. L. and Pyne, N. J. (2009) The role of the PDE4D cyclic AMP phosphodiesterase in the regulation of glucagon-like peptide-1 (GLP-1) release. Br J Pharmacol 157: 633-644. (impact factor 5.204, Scopus-indexed)

Furman, B. L., Ong, W. K. and Pyne, N. J. (2009) Cyclic AMP signalling in pancreatic islets. Advances in Experimental Medicine and Biology: The Islets of Langerhans: 281-304. (impact factor 2.02, Scopus-indexed)

Conference Proceedings (Refereed Only)

Ong, W. K. and Sugii, S. CD10 is a potential biomarker of adipogenic potential and fat quality. Malaysian Society of Pharmacology and Physiology Scientific Meeting, 2017, Aug, 18-19, Kota Bharu, Malaysia

Ong, W. K. and Sugii, S. Use of adipogenic biomarker CD10 to screen for adipogenic capability of adipose-derived stem cells from different adipose depots. Malaysian Tissue Engineering and Regenerative Medicine Scientific Meeting, 2016, Nov, 17-18, Seberang Jaya, Malaysia

Ong, W. K., Toh, S., Han, W. and Sugii, S. Use of fat depot-specific adipose-derived stem cell biomarkers for high throughput screening and diagnosis. International Society for Stem Cell Research, 2014, Jun, 18-21, Vancouver, Canada

Ong, W. K., Han, W. and Sugii, S. Cell surface marker profiling of adipose-derived stem cells from human subcutaneous and visceral depots. Stem Cell Society Singapore Symposium, 2012, Sep, 6-7, Singapore, Singapore

Ong, W. K., Smith, G. C., Rewcastle, G. W., Kendall, J. D., Han, W. and Shepherd, P. R. Acute and chronic effects of class-I phosphatidylinositol (PI) 3-kinase inhibitors on feeding behaviour, energy expenditure and locomotive activity in mice. Queenstown Molecular Biology Meetings: Signalling, 2011, Aug, 28-29, Queenstown, New Zealand

Ong, W. K., Houslay, M. D., Lynch, M. J., Baillie, G. S., Pyne, N. J. and Furman, B. L. (2007) Evidence for the role of the phosphodiesterase (PDE) isoform PDE4D in regulating glucagon-like peptide (GLP-1) secretion in the GLUTag cell line. Diabetologia 50: S286. European association for the study of diabetes, 2007, Sep, 17-21, Amsterdam, the Netherlands.

Ong, W. K., Gribble, F. M., Reimann, F., Pyne, N. J. and Furman, B. L. Cyclic nucleotide phosphodiesterases in GLUTag cells. Bioscience, 2006, Jul, 23-27, Glasgow, UK.

No content

No content

No content